STOCK TITAN

Vanguard affiliates to report separately as ABSI holdings shift (ABSI)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Absci Corp amendment to a Schedule 13G/A shows The Vanguard Group reports zero shares beneficially owned and 0% of Absci Corp common stock following an internal realignment. The filing clarifies that certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after internal disaggregation.

The filing states The Vanguard Group beneficially owns 0 shares and 0% of common stock as reported in Item 4. The statement attributes the change to an internal realignment and reliance on SEC Release No. 34-39538.

Cash‑flow treatment and any previously reported holdings are not included in the excerpt; subsequent filings from Vanguard's separate entities may disclose holdings individually.

Amendment documents compliance with SEC disaggregation guidance.

The document references SEC Release No. 34-39538 and explains that subsidiaries or divisions will report beneficial ownership separately. This is a procedural compliance disclosure rather than a transaction or change in economic ownership described here.

Watch for follow-up 13G/A filings from Vanguard affiliates for any reported holdings in Absci Corp.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Absci Corp's Schedule 13G/A from Vanguard state about ownership?

It states The Vanguard Group beneficially owns 0 shares, representing 0% of common stock. The filing attributes this reporting status to an internal realignment and disaggregation under SEC Release No. 34-39538.

Does this filing mean Vanguard sold Absci Corp shares?

No. The filing explains an internal realignment and separate reporting by subsidiaries; it does not state a sale or describe cash proceeds. It documents a change in reporting structure under SEC guidance.

Will other Vanguard entities report holdings in ABSI separately?

Yes. The amendment says certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538. Those affiliates may file their own disclosure forms if they hold shares.

Who signed the Schedule 13G/A amendment for Vanguard?

Ashley Grim, Head of Global Fund Administration, signed the amendment on 03/26/2026. The filing lists Vanguard's principal business office at 100 Vanguard Blvd., Malvern, PA.
Absci Corp

NASDAQ:ABSI

View ABSI Stock Overview

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

440.70M
128.99M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER